The Effects of Mucolytic Agents N-Acetylcysteine and Erdosteine on Hemostasis in Humans

There are some indications in a few studies on animals and humans that the mucolytic agents N-acetylcysteine and erdosteine have a disruptive effect on the coagulation cascade.

This study aimed to examine the effects of both erdosteine and N-acetylcysteine on the coagulation pathway.

Materials and Methods. The research was conducted on patients treated with N-acetylcysteine (600 mg/day) or erdosteine (600 mg/day) for 7–14 days. To evaluate the coagulation and hemogram parameters, blood samples were taken from patients before treatment and on days 7–14 after starting the treatment. Hemogram and coagulation parameters were measured in the venous blood samples.

Results. The levels of factor II significantly decreased, and the platelet count significantly increased in patients treated with erdosteine. D-dimer levels reduced and factor VII levels increased in patients treated with N-acetylcysteine, but these changes were not significant (p=0.069 and p=0.062, respectively). Other coagulation and hemogram values did not change in both groups. Erdosteine may have a dualistic effect on the coagulation cascade through its different metabolites.

1. Rogliani P., Matera M.G., Page C., Puxeddu E., Cazzola M., Calzetta L. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respir Res 2019; 20(1): 104, https://doi.org/10.1186/s12931-019-1078-y.
2. Jepsen S., Hansen A.B. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest 1994; 54(7): 543–547, https://doi.org/10.3109/00365519409088566.
3. Knudsen T.T., Thorsen S., Jensen S.A., Dalhoff K., Schmidt L.E., Becker U., Bendtsen F. Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects. Gut 2005; 54(4): 515–521, https://doi.org/10.1136/gut.2004.043505.
4. Niemi T.T., Munsterhjelm E., Pöyhiä R., Hynninen M.S., Salmenperä M.T. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 2006; 17(1): 29–34, https://doi.org/10.1097/01.mbc.0000195922.26950.89.
5. Wijeysundera D.N., Karkouti K., Rao V., Granton J.T., Chan C.T., Raban R., Carroll J., Poonawala H., Beattie W.S. N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med 2009; 37(6): 1929–1934, https://doi.org/10.1097/CCM.0b013e31819ffed4.
6. Smyrniotis V., Arkadopoulos N., Kostopanagiotou G., Theodoropoulos T., Theodoraki K., Farantos C., Kairi E., Paphiti A. Attenuation of ischemic injury by N-acetylcysteine preconditioning of the liver. Journal of Surgical Research 2005; 129(1): 31–37.
7. Arica V., Tutanc M., Ozturk O.H., Arica S., Basarslan F., Erden E.S., Oktar S., Kaya H. Dual effects of erdosteine on hemostasis via its different metabolites in young rats. Hum Exp Toxicol 2011; 30(10): 1644–1648, https://doi.org/10.1177/0960327110396526.
8. Tutanc M., Arica V., Motor S., Basarslan F., Erden E.S., Ozturk O.H., Zararsiz I., Aydin M. Effects of erdosteine on hemostasis: an experimental study. Hum Exp Toxicol 2012; 31(6): 574–578, https://doi.org/10.1177/0960327111426588.
9. Motor S., Alp H., Yuksel R., Erden E., Oktar S., Celik S., Cayirci G., Yilmaz E. The effects of erdosteine on coagulation in rats. Acta Medica Mediterranea 2014; 30: 801.
10. Smeeth L., Cook C., Thomas S., Hall A.J., Hubbard R., Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367(9516): 1075–1079, https://doi.org/10.1016/S0140-6736(06)68474-2.
11. Majoor C.J., van de Pol M.A., Kamphuisen P.W., Meijers J.C., Molenkamp R., Wolthers K.C., van der Poll T., Nieuwland R., Johnston S.L., Sterk P.J., Bel E.H., Lutter R., van der Sluijs K.F. Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study. Respir Res 2014; 15(1): 14, https://doi.org/10.1186/1465-9921-15-14.
12. Assinger A. Platelets and infection — an emerging role of platelets in viral infection. Front Immunol 2014, https://doi.org/10.3389/fimmu.2014.00649.
13. Bouwman J.J., Visseren F.L., Bosch M.C., Bouter K.P., Diepersloot R.J. Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest 2002; 32(10): 759–766, https://doi.org/10.1046/j.1365-2362.2002.01041.x.
14. Goeijenbier M., van Wissen M., van de Weg C., Jong E., Gerdes V.E., Meijers J.C., Brandjes D.P., van Gorp E.C. Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol 2012; 84(10): 1680–1696, https://doi.org/10.1002/jmv.23354.
15. Keller T.T., van Wissen M., Mairuhu A.T., van Doornum G.J., Brandjes D.P. Acute respiratory tract infections in elderly patients increase systemic levels of hemostatic proteins. J Thromb Haemost 2007; 5(7): 1567–1569, https://doi.org/10.1111/j.1538-7836.2007.02580.x.
16. Jang D.H., Weaver M.D., Pizon A.F. In vitro study of N-acetylcysteine on coagulation factors in plasma samples from healthy subjects. J Med Toxicol 2013; 9(1): 49–53, https://doi.org/10.1007/s13181-012-0242-2.
17. Khalili F., Khosravi M.B., Sahmeddini M.A., Eghbal M.H., Kazemi K., Nikeghbalian S., Ghazanfar Tehran S., Khosravi B. The effect of perioperative N-acetylcysteine on the short and long term outcomes in pediatrics undergoing living-donor liver transplantation. Int J Organ Transplant Med 2021; 12(1): 12–20.
18. Pizon A.F., Jang D.H., Wang H.E. The in vitro effect of N-acetylcysteine on prothrombin time in plasma samples from healthy subjects. Acad Emerg Med 2011; 18(4): 351–354, https://doi.org/10.1111/j.1553-2712.2011.01041.x.
19. Thorsen S., Teisner A., Jensen S.A., Philips M., Dalhoff K., Bendtsen F. Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature. Scand J Clin Lab Invest 2009; 69(6): 643–650, https://doi.org/10.3109/00365510902943262.
20. Marley R., Patel R.P., Orie N., Ceaser E., Darley-Usmar V., Moore K. Formation of nanomolar concentrations of S-nitroso-albumin in human plasma by nitric oxide. Free Radic Biol Med 2001; 31(5): 688–696, https://doi.org/10.1016/s0891-5849(01)00627-x.
21. Kim K.Y., Rhim T., Choi I., Kim S.S. N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity. J Biol Chem 2001; 276(44): 40591–40598, https://doi.org/10.1074/jbc.M100975200.
22. Bresette C.A., Ashworth K.J., Di Paola J., Ku D.N. N-acetyl cysteine prevents arterial thrombosis in a dose-dependent manner in vitro and in mice. Arterioscler Thromb Vasc Biol 2024; 44(2): e39–e53, https://doi.org/10.1161/ATVBAHA.123.319044.
23. Naraki K., Mousavi S.H., Etemad L., Rezazadeh-Shojaie S.M., Sadeghi T., Moshiri M. N-acetylcysteine overdose: a case report. International Journal of Medical Toxicology and Forensic Medicine 2021; 11(1): 32409, https://doi.org/10.32598/ijmtfm.v11i1.32409.
24. Bueche C.Z., Garz C., Kropf S., Bittner D., Li W., Goertler M., Heinze H.J., Reymann K., Braun H., Schreiber S. NAC changes the course of cerebral small vessel disease in SHRSP and reveals new insights for the meaning of stases — a randomized controlled study. Exp Transl Stroke Med 2013; 5: 5, https://doi.org/10.1186/2040-7378-5-5.
25. Martinez de Lizarrondo S., Gakuba C., Herbig B.A., Repessé Y., Ali C., Denis C.V., Lenting P.J., Touzé E., Diamond S.L., Vivien D., Gauberti M. Potent thrombolytic effect of N-acetylcysteine on arterial thrombi. Circulation 2017; 136(7): 646–660, https://doi.org/10.1161/circulationaha.117.027290.
26. Olsson B., Johansson M., Gabrielsson J., Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 1988; 34(1): 77–82, https://doi.org/10.1007/BF01061422.
27. Dechant K.L., Noble S. Erdosteine. Drugs 1996; 52(6): 875–882, https://doi.org/10.2165/00003495-199652060-00009.
28. Cazzola M., Page C., Rogliani P., Calzetta L., Matera M.G. Multifaceted beneficial effects of erdosteine: more than a mucolytic agent. Drugs 2020; 80(17): 1799–1809, https://doi.org/10.1007/s40265-020-01412-x.
29. Cattò C., Villa F., Cappitelli F. Understanding the role of the antioxidant drug erdosteine and its active metabolite on staphylococcus aureus methicillin resistant biofilm formation. Antioxidants (Basel) 2021; 10(12): 1922, https://doi.org/10.3390/antiox10121922.
30. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 1998; 158(19): 2101–2106, https://doi.org/10.1001/archinte.158.19.2101.
31. Roca B., Roca M., Girones G. Increased homocysteine plasma level is associated with shortened prothrombin time in HIV-infected patients. HIV Clin Trials 2016; 17(5): 218–223, https://doi.org/10.1080/15284336.2016.1220712.
32. da Cunha A.A., Scherer E., da Cunha M.J., Schmitz F., Machado F.R., Lima D.D., Delwing D., Wyse A.T. Acute hyperhomocysteinemia alters the coagulation system and oxidative status in the blood of rats. Mol Cell Biochem 2012; 360(1–2): 205–214, https://doi.org/10.1007/s11010-011-1058-0.
33. Nasri H. Impact of serum homocysteine on platelet count in stable hemodialysis patients. The Journal of Applied Research 2006; 6(1): 14–18.
34. Yassin M., Lubbad A.M., Abu Taha A., Saadallah N. Homocysteine and hematological indices in hemodialysis patients. Ibnosina Journal of Medicine and Biomedical Sciences 2014; 06(04): 173–179, https://doi.org/10.4103/1947-489x.210380.
35. Zanin R.F., Campesato L.F., Braganhol E., Schetinger M.R., Wyse A.T., Battastini A.M. Homocysteine decreases extracellular nucleotide hydrolysis in rat platelets. Thromb Res 2010; 125(3): e87–92, https://doi.org/10.1016/j.thromres.2009.09.020.

Oktar S., Doğru S., Motor S., Demirköse M., Erden E.Ş. The Effects of Mucolytic Agents N-Acetylcysteine and Erdosteine on Hemostasis in Humans. Sovremennye tehnologii v medicine 2024; 16(4): 55, https://doi.org/10.17691/stm2024.16.4.06